SARS-CoV-2 Trasmission and Outcome in Neuro-rehabilitation patients hospitalized at Neuroscience Hospital in Italy
Conclusions: In 13 out of 14 patients, the infection was asymptomatic; this is particularly intriguing considering their severe neurological clinical profile. According to the pivotal role played by inflammation and activation of blood coagulation in the pathogenesis of COVID-19, the anti-inflammatory and anticoagulant properties of enoxaparin, administered much earlier and during infection, could have favored an extremely benign disease course in these patients at high risk of poor outcome.Keywords: SARS CoV 2, neurological patients, neurological damage, Infection, Coronavirus
Source: Mediterranean Journal of Hematology and Infectious Diseases - Category: Hematology Authors: Francesco Di Gennaro Source Type: research
More News: Brain | Coronavirus | COVID-19 | Diabetes | Diabetes Mellitus | Disability | Endocrinology | Hematology | Hypertension | Infectious Diseases | Italy Health | Laboratory Medicine | Lovenox | Neurology | Outbreaks | Rehabilitation | Respiratory Medicine | SARS